PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $144,000 | -68.9% | 45,861 | -71.2% | 0.00% | -100.0% |
| Q2 2020 | $463,000 | +1087.2% | 159,019 | +1044.1% | 0.00% | – |
| Q1 2020 | $39,000 | -98.3% | 13,899 | -98.0% | 0.00% | -100.0% |
| Q4 2019 | $2,242,000 | +317.5% | 690,871 | +177.9% | 0.00% | +200.0% |
| Q3 2019 | $537,000 | -59.7% | 248,620 | -41.4% | 0.00% | -50.0% |
| Q2 2019 | $1,332,000 | +420.3% | 424,052 | +517.4% | 0.00% | – |
| Q1 2019 | $256,000 | -70.0% | 68,688 | -76.6% | 0.00% | -100.0% |
| Q4 2018 | $852,000 | +61.1% | 293,842 | +46.1% | 0.00% | 0.0% |
| Q3 2018 | $529,000 | +1130.2% | 201,145 | +994.5% | 0.00% | – |
| Q2 2018 | $43,000 | -94.3% | 18,377 | -92.8% | 0.00% | -100.0% |
| Q1 2018 | $754,000 | -82.6% | 256,541 | -83.7% | 0.00% | -83.3% |
| Q4 2017 | $4,323,000 | -63.8% | 1,577,606 | -55.2% | 0.01% | -66.7% |
| Q3 2017 | $11,935,000 | +982.0% | 3,520,598 | +688.3% | 0.02% | +800.0% |
| Q2 2017 | $1,103,000 | +322.6% | 446,588 | +288.1% | 0.00% | – |
| Q1 2017 | $261,000 | -81.5% | 115,061 | -82.7% | 0.00% | -100.0% |
| Q4 2016 | $1,409,000 | +61.4% | 664,770 | +155.1% | 0.00% | +200.0% |
| Q3 2016 | $873,000 | -53.2% | 260,589 | -56.1% | 0.00% | -75.0% |
| Q2 2016 | $1,864,000 | -67.0% | 593,778 | -65.0% | 0.00% | -71.4% |
| Q1 2016 | $5,642,000 | -34.6% | 1,694,387 | -30.4% | 0.01% | -22.2% |
| Q4 2015 | $8,623,000 | +210.3% | 2,435,772 | +340.8% | 0.02% | +260.0% |
| Q3 2015 | $2,779,000 | -51.8% | 552,576 | -38.4% | 0.01% | -54.5% |
| Q2 2015 | $5,765,000 | -35.7% | 896,615 | -29.6% | 0.01% | -35.3% |
| Q1 2015 | $8,966,000 | +325.7% | 1,274,446 | +366.6% | 0.02% | +325.0% |
| Q4 2014 | $2,106,000 | +71.9% | 273,106 | +66.6% | 0.00% | +33.3% |
| Q3 2014 | $1,225,000 | +185.5% | 163,973 | +217.8% | 0.00% | +200.0% |
| Q1 2014 | $429,000 | -37.6% | 51,600 | -36.7% | 0.00% | -50.0% |
| Q4 2013 | $688,000 | +203.1% | 81,500 | +185.6% | 0.00% | +100.0% |
| Q3 2013 | $227,000 | -68.1% | 28,541 | -69.1% | 0.00% | -50.0% |
| Q2 2013 | $712,000 | – | 92,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |